SQUAWK/NEWS
Menu
Live News EQUITY L impact

NNVC nanoviricides, Inc: sufficient quantity of NV-387 oral gummies drug product for starting clinical trial against ebola is already availa

NNVC nanoviricides, Inc: sufficient quantity of NV-387 oral gummies drug product for starting clinical trial against ebola is already available in drc

NNVC

NNVC nanoviricides, Inc: sufficient quantity of NV-387 oral gummies drug product for starting clinical trial against ebola is already available in drc